Hiroyuki Hata
- Molecular Biology top 10%
- Oncology top 10%
- Hematology top 2%
- Immunology top 10%
- Epidemiology
- Co-authors
- Hiroaki MitsuyaYutaka OkunoYawara KawanoHiromitsu MatsuzakiShiho FujiwaraFumihiko MatsunoTakayuki EzakiNaoko Wada
- Topics
- Multiple Myeloma Research and Treatments (30 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers)Peptidase Inhibition and Analysis (13 papers)
- Cited by
- HematologyMicrobiologyEndocrinology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroyuki Hata
93 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 788
- Oncology 447
- Hematology 439
- Immunology 286
- Epidemiology 167
Countries citing papers authored by Hiroyuki Hata
This map shows the geographic impact of Hiroyuki Hata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Hata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Hata more than expected).
Fields of papers citing papers by Hiroyuki Hata
This network shows the impact of papers produced by Hiroyuki Hata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Hata. The network helps show where Hiroyuki Hata may publish in the future.
Co-authorship network of co-authors of Hiroyuki Hata
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Hata. A scholar is included among the top collaborators of Hiroyuki Hata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Hata. Hiroyuki Hata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 18 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 42 | |
| 10 | 8 | |
| 11 | [Development of novel agents for multiple myeloma; now and the future]. | 1 |
| 12 | 11 | |
| 13 | 17 | |
| 14 | 41 | |
| 15 | 55 | |
| 16 | 8 | |
| 17 | 7 | |
| 18 | 17 | |
| 19 | 3 | |
| 20 | 4 |
About Hiroyuki Hata
Hiroyuki Hata is a scholar working on Hematology, Microbiology and Oncology, having authored 96 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Peptidase Inhibition and Analysis (13 papers). The work is most often cited by research in Hematology (439 citations), Microbiology (18 citations) and Endocrinology (92 citations). Hiroyuki Hata has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroaki Mitsuya, Yutaka Okuno, Yawara Kawano, Hiromitsu Matsuzaki, Shiho Fujiwara, Fumihiko Matsuno, Takayuki Ezaki, Naoko Wada, Pham Hong Nhung and Hiro Tatetsu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.